For example, the ADH-1 (Exherin), is an anticancer peptide distributed by Adhex Technologies®, which targets N-cadherin and induced partial and complete protective responses in patients with metastatic melanoma (49). The gene discussed is ADH1A; the disease is metastatic melanoma.